Evidence map›Paper›PMID 30508952›Full record

ArticleMedicine2018

Thrombosis in the portal venous system caused by hypereosinophilic syndrome: A case report.

Jinfeng Lin, Xiaoying Huang, Weihua Zhou, Suyan Zhang, Weiwei Sun, Yadong Wang, Ke Ren, Lijun Tian, Junxian Xu, Zhilong Cao and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hyepereosiniphilic syndrome and COVID-19: 2 case reports.Journal of cardiothoracic surgery · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jinfeng LinDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Xiaoying HuangDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Weihua ZhouDepartment of Critical Care Medicine, Hai'an County People's Hospital, Nantong, China.
Suyan ZhangDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Weiwei SunDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Yadong WangDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Ke RenDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Lijun TianDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Junxian XuDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Zhilong CaoDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Zunguo PuDepartment of Critical Care Medicine, Hai'an County People's Hospital, Nantong, China.
Xudong HanDepartment of Critical Care Medicine, Nantong Third People's Hospital, Nantong University.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleExtensive thrombosis in the portal venous system caused by hypereosinophilic syndrome (HES) is rare, and there is no consensus on anticoagulant and thrombolytic treatments for arteriovenous thrombosis caused by HES. PATIENT CONCERNS: The clinical data of a patient with extensive thrombosis in his portal venous system (superior mesenteric, splenic, hepatic, and portal veins), renal artery thrombosis, and mesenteric thrombosis caused by HES with secondary gastrointestinal bleeding and intestinal necrosis were retrospectively analyzed. Before admission, his eosinophil count increased to 7.47 × 10/L, and HES had been confirmed via bone marrow cytology. The patient experienced fever, cough, abdominal pain, massive hematemesis, and hematochezia that developed in succession. Abdominal computed tomography showed portal vein and superior mesenteric vein thromboses. DIAGNOSIS: Hypereosinophilic syndrome; extensive thrombosis in the portal venous system; acute eosinophil-associated pneumonia; gastrointestinal bleeding; intestinal necrosis.

interventionsThe patient was first treated with methylprednisolone, plasma exchange/hemofiltration, and single or combined use of unfractionated heparin and argatroban for anticoagulation. He was also administered alteplase and urokinase, successively, for thrombolytic treatment. Once the thromboses finally disappeared, the patient underwent surgery to excise a necrotic intestinal canal. OUTCOMES: The thromboses disappeared with these treatments, and the patient recovered after the necrotic intestinal canal was excised. LESSONS: The clinical manifestations of HES are complex and varied, and this condition can cause severe and extensive arteriovenous thrombosis. Anticoagulation therapy and thrombolysis are necessary interventions, and appear to be safe and effective.

Indexed as

Portal SystemArginineCritical IllnessDrug Therapy, CombinationFibrinolytic AgentsGastrointestinal HemorrhageHeparinHumansHypereosinophilic SyndromeMalePipecolic AcidsPlasma ExchangePlatelet Aggregation InhibitorsPulmonary EosinophiliaSulfonamidesTissue Plasminogen ActivatorargatrobanArginineFibrinolytic AgentsHeparinPipecolic AcidsPlatelet Aggregation InhibitorsSulfonamidesTissue Plasminogen ActivatorUrokinase-Type Plasminogen Activator

Identifiers

PMID30508952
PMCPMC6283207
OpenAlexW2902008376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.